In fact, a LNP formulation based on DLin-MC3-DMA (16), one of the most potent lipids identified in this work, is currently being utilized in a clinical trial for treating hypercholesterolemia; the target is PCSK9 and the data (not shown) indicate decreases in LDL-C after a single low dose.[ 17, 18] Detailed facts of importance to specialist readers are published as "Supporting Information".
The inability of traditional methods for capturing adverse events has led to renewed interest in incorporating patient-reported outcomes (PROs/PROMs) with Common Terminology Criteria for Adverse Events (CTC-AEs) in clinical trials, as well as utilizing PROs outside a clinical trial setting to reflect and monitor more accurately the harms and benefits of patient experience.
A clinical trial utilizing a neutralizing antibody directed at myostatin did not improve muscle function or increase muscle mass in adult patients with muscular dystrophy [53].
Although antioxidant treatments in animal models are encouraging, researchers prematurely terminated a clinical trial utilizing high doses of vitamins C and E in women with alcohol-exposed pregnancies because of safety concerns (Goh et al. 2007).
Community-based participatory research was utilized to design and prepare a clinical trial that randomizes recent survivors of interpersonal violence who have PTSD, depression, and insomnia to receive either: (1) Cognitive Behavioral Therapy for Insomnia (CBTi) followed by Cognitive Processing Therapy (CPT) for trauma, or (2) attention control followed by CPT.
Validation of specific targets within what may be a multitude of changes will be challenging and difficult to accomplish utilizing only previous clinical trial designs.
The applicability of the genetic biomarker in the human population must then be verified through both retrospective studies utilizing stored or clinical trial samples, and through clinical trials prospectively stratifying patients based on the biomarker.
Reporting methodology is highly variable and nonstandardized, yet surgical outcomes are utilized in clinical trial design and evaluation of healthcare provider performance.
To assess if these non-SCZ drugs have potential to treat SCZ, we utilized the clinical trial studies to examine how many drugs have been investigated in schizophrenia or other mental diseases.
Additionally, by strategically utilizing pragmatic clinical trials to test therapies and interventions that have previously shown efficacy in younger, fitter patients, these trials represent a potential mechanism to improve the evidence base in geriatric oncology and enhance care for older adults with cancer.
